Patent-pending NR, NRH, NMN/NMNH, and BioPeak®-NAD technologies designed to improve selected active-ingredient delivery, support differentiated premium product lines, and create strategic value across science-driven longevity portfolios.
Filed IP Platforms for Advanced NAD+ and Premium Longevity Innovation
Strategic Differentiation Through Protected NAD+ and Absorption Platforms
RejuvaTech LLC develops filed IP platforms for next-generation NAD+ precursor technologies, advanced oral delivery systems, stabilized longevity actives, and premium dietary supplement innovation. The portfolio is designed for qualified corporate partners seeking differentiated product architectures across pharmacy, health-beauty, longevity, and premium wellness channels.
Core Platform Areas
BioPeak®-NAD: Advanced absorption architecture for selected NAD+ precursors and high-value wellness actives.
RiboGEN® Platform: Next-generation NR-related technologies designed for differentiated NAD+ support positioning.
RiboGEN® II: Stabilized NRH platform for future NAD+ precursor innovation.
BioPeak®-TR: Advanced triterpenoid delivery platform for skin, beauty-from-within, and mobility categories.
Corporate Development & Strategic Review
RejuvaTech is evaluating qualified strategic acquisition, licensing, co-development, manufacturing, and platform-commercialization inquiries. Technical packages, patent summaries, formulation details, freedom-to-operate materials, and supporting data are available only under NDA.
FUTURE NAD+ PRECURSOR PLATFORM
RiboGEN® II: Stabilized NRH Platform for Next-Generation NAD+ Innovation
RiboGEN® II is RejuvaTech’s stabilized NRH platform designed to support future NAD+ precursor innovation beyond conventional NR, NMN, and commodity NAD+ products.
NRH is widely recognized as a high-potential reduced NAD+ precursor, but practical product development has historically been limited by instability, oxidation sensitivity, moisture sensitivity, powder-handling challenges, and finished-product delivery constraints.
RejuvaTech’s stabilized NRH platform is designed to address these limitations through protected chemistry, stabilized composition design, manufacturing pathway development, and BioPeak®-NAD delivery integration.
When paired with BioPeak®-NAD, RiboGEN® II may support a future premium NAD+ product class with stronger differentiation, higher perceived value, and long-term strategic platform control.
Detailed chemistry, stabilization data, sample status, manufacturing pathways, and product-specific applications are available only under NDA and staged technical diligence.
SKIN, BEAUTY-FROM-WITHIN, AND MOBILITY PLATFORM
BioPeak®-TR: Advanced Triterpenoid Delivery Platform
BioPeak®-TR is RejuvaTech’s advanced triterpenoid delivery platform designed to support premium skin, beauty-from-within, mobility, and healthy-aging product development.
Triterpenoid and botanical actives are commercially attractive but often limited by poor solubility, inconsistent absorption, and difficult formulation characteristics. BioPeak®-TR is designed to improve delivery potential for selected high-value actives and create differentiated product architectures for premium wellness and health-beauty brands.
The platform may support future product classes across skin elasticity, beauty-from-within, joint and mobility support, botanical longevity, and advanced topical or oral delivery formats.
RejuvaTech’s goal is to create protected, science-driven platform technologies that allow qualified partners to move beyond commodity botanical extracts and into higher-value proprietary product categories.
Detailed formulation architecture, delivery strategy, supporting data, and product-specific applications are available only under NDA and staged technical diligence.
GMP-READY COMMERCIALIZATION SUPPORT
Technical Integration for Scalable Premium Product Deployment
RejuvaTech supports qualified strategic partners with the technical integration needed to move protected platform technologies from IP review into scalable premium product development.
The RejuvaTech platform is not limited to ingredient concepts. It is designed to support practical commercialization through formulation architecture, excipient strategy, finished-dose planning, GMP manufacturing interface, and product-positioning support.
This integration capability allows strategic partners to evaluate how BioPeak®-NAD, RiboGEN® next-generation NR, RiboGEN® II stabilized NRH, and BioPeak®-TR technologies may be adapted into premium longevity, pharmacy, health-beauty, and advanced wellness product lines.
Where appropriate, RejuvaTech can support partner GMP facilities, contract manufacturers, and commercialization teams through staged technical transfer, formulation review, product-development planning, and NDA-protected diligence.
The result is a more efficient path from protected chemistry and platform IP to finished premium product architecture.